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Abstract. Background: Fifteen 3-styrylchromones were
subjected to quantitative structure–activity relationship
(QSAR) analysis based on their cytotoxicity, tumor selectivity
and anti-HIV activity, in order to explore their biological
activities. Materials and Methods: Cytotoxicity against four
human oral squamous cell carcinoma (OSCC) cell lines and
three human oral normal cells was determined by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
method. Tumor-selectivity was evaluated by the ratio of the
mean CC50 (50% cytotoxic concentration) against normal
human oral cells to that against OSCC cell lines. Anti-HIV
activity was evaluated by the ratio of CC50 to EC50 (50%
cytoprotective concentration from HIV infection).
Physicochemical, structural and quantum-chemical
parameters were calculated based on the conformations
optimized by the LowModeMD method followed by the
density functional theory (DFT) method. Results: All 3-
styrylchromone derivatives showed moderate-to-high tumor
selectivity. Especially, compounds that have a methoxy group
at 6-position of the chromone ring and hydroxyl group at 4’-
position of phenyl group in styryl moiety [11] showed the
highest tumor-selectivity. On the other hand, their
cytotoxicity against normal cells showed good correlation to
the descriptors that reflect hydrophobic interaction and
molecular shapes. Conclusion: Multivariate statistics with
chemical descriptors for the location of substituted group,
molecular shape and electrostatic interaction may be useful
for designing the most favorable compound with higher
tumor selectivity.
4H-1-benzopyran-4-ones (chromones) are an important class
of oxygenated heterocyclic compounds since the chromone
core structure is found in flavones, isoflavones and 2-
styrylchromones. As compared with flavones and
isoflavones, 2-styrylchromones constitute a much smaller
group of naturally occurring chromones. Synthetic 2-
styrylchromones showed antioxidant (1), anti-allergic (2),
anti-inflammatory (3), anti-tumor (4-6), anti-viral (7, 8)
activities. In contrast, as far as we know there were only two
papers of 3-styrylchromones that investigated the antiviral
(9) and antibacterial activity (10). 
In order to further explore novel biological activities of 3-
styrylchromones, we recently synthesized a series of 3-
styrylchromone derivatives and reported antioxidant and α-
glucosidase inhibition activities (11). In the present study, we
investigated the cytotoxicity and anti-HIV activity of fifteen
3-styrylchromones and then performed the quantitative
structure–activity relationship (QSAR) analysis.
For the cytotoxicity assay, both human normal oral cells
(gingival fibroblast, HGF; pulp cells, periodontal ligament
fibroblast, HPLF; pulp cell, HPC) and human oral squamous
cell carcinoma (OSCC) cell lines (Ca9-22, HSC-2, HSC-3,
HSC-4) were used as target cells. The anti-tumor potential
was evaluated by the tumor-selectivity index (TS), calculated
by dividing the mean 50% cytotoxic concentration (CC50)
against normal oral cells by that against OSCC cell lines. We
have already confirmed that the TS value determined by this
method reflects the anti-tumor potential of test samples,
although these normal oral cells and OSCC cell lines are
classified as different types of cells (mesenchymal or
epithelial) (12).
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For the anti-HIV assay, mock- and HIV-infected-human T-
cell lymphotropic virus-I (HTLV-I) carrying human T-cell
line MT4 was used. The selectivity index (SI) was calculated
by dividing the CC50 by the 50% cytoprotective
concentration from HIV infection (EC50).
Materials and Methods
Materials. The following chemicals and reagents were obtained from
the indicated companies: Dulbecco’s modified Eagle’s medium
(DMEM), from GIBCO BRL, Grand Island, NY, USA; fetal bovine
serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), azidothymidine and 2’,3’-dideoxycytidine from
Sigma-Aldrich Inc., St. Louis, MO, USA; dimethyl sulfoxide
(DMSO), dextran sulfate (molecular mass, 5 kDa) from Wako Pure
Chem. Ind., Osaka, Japan; 5-fluorouracil (5-FU) from Kyowa, Tokyo,
Japan; curdlan sulfate (molecular mass, 79 kDa) from Ajinomoto Co.
Ltd., Tokyo, Japan. Culture plastic dishes and plates (96-well) were
purchased from Becton Dickinson (Franklin Lakes, NJ, USA). 
Synthesis of test compounds. (E)-3-(4-Methoxystyryl)-4H-chromen-
4-one [1], (E)-3-(3,4-Dimethoxystyryl)-4H-chromen-4-one [2], (E)-
3-(3,4,5-Trimethoxystyryl)-4H-chromen-4-one [3], (E)-6-Methoxy-
3-(4-methoxystyryl)-4H-chromen-4-one [4], (E)-6-Methoxy-3-(3,4-
dimethoxystyryl)-4H-chromen-4-one [5], (E)-6-Methoxy-3-(3,4,5-
trimethoxystyryl)-4H-chromen-4-one [6], (E)-3-(4-Fluorostyryl)-6-
methoxy-4H-chromen-4-one [7], (E)-3-(4-Chlorostyryl)- 6-
methoxy-4H-chromen-4-one [8], (E)-3-(4-Hydroxystyryl)-4H-
chromen-4-one [9], (E)-3-(3,4-Dihydroxystyryl)-4H-chromen-4-one
[10], (E)-3-(4-Hydroxystyryl)- 6-methoxy-4H-chromen-4-one [11],
(E)-3-(3,4-Dihydroxystyryl)- 6-methoxy-4H-chromen-4-one [12],
(E)-6-Hydroxy-3-(4-methoxystyryl)-4H-chromen-4-one [13], (E)-6-
Hydroxy-3-(4-hydroxystyryl)-4H-chromen-4-one [14] and (E)-6-
Hydroxy-3-(3,4-dihydroxystyryl)-4H-chromen-4-one [15] (Figure 1)
were synthesized by Knoevenagel condensation of the appropriate
3-formylchromone with selected phenylacetic acid derivatives,
according to previous methods (11). All compounds were dissolved
in DMSO at 80 mM and stored at –20˚C before use. 
Cell culture. HGF, HPLF and HPC cells, established from the first
premolar tooth extracted from the lower jaw of a 12-year-old girl
(13), and OSCC cell lines (Ca9-22, HSC-2, HSC-3, HSC-4),
purchased from Riken Cell Bank, Tsukuba, Japan were cultured at
37°C in DMEM supplemented with 10% heat-inactivated FBS, 100
units/ml, penicillin G and 100 μg/ml streptomycin sulfate under a
humidified 5% CO2 atmosphere. Cells were then harvested by
treatment with 0.25% trypsin-0.025% EDTA-2Na in PBS(−) and
either subcultured or used for experiments.
Assay for cytotoxic activity. Cells were inoculated at 2.5×103 cells/0.1
ml in a 96-microwell plate (Becton Dickinson Labware, Franklin
Lakes, NJ, USA). After 48 hours, the medium was removed by
suction with an aspirator and replaced with 0.1 ml of fresh medium
containing different concentrations of single test compounds. Control
cells were treated with the same amounts of DMSO present in each
diluent solution. Cells were incubated for 48 hours and the relative
viable cell number was then determined by the MTT method. In brief,
the treated cells were incubated for another three hours in fresh
culture medium containing 0.2 mg/ml MTT. Cells were then lysed
with 0.1 ml of DMSO and the absorbance at 540 nm of the cell lysate
was determined using a microplate reader (Biochromatic Labsystem,
Helsinki, Finland). The CC50 was determined from the dose–response
curve and the mean value of CC50 for each cell type was calculated
from three independent experiments. 
Calculation of TS. The tumor-selectivity index (TS) was calculated
by the following equation: TS=mean CC50 against normal cells/mean
CC50 against tumor cells [(D/B) in Table I]. Since Ca9-22 cells were
derived from gingival tissue (14), the relative sensitivity of Ca9-22
and HGF was also compared [(C/A) in Table I]. 
Assay for HIV activity. HTLV-I-carrying human T-cell line MT4
cells, highly sensitive to human immunodeficiency virus-1 (HIV-1),
were infected with HIV-1IIIB at a multiplicity of infection (m.o.i.)
of 0.01. HIV- and mock-infected (control) MT-4 cells were
incubated for five days with different concentrations of samples and
the relative viable cell number was determined by the MTT assay.
The CC50 and EC50 were determined from the dose–response curve
for mock-infected and HIV-infected cells, respectively (15). All data
represent the mean values of triplicate measurements. The anti-HIV
activity was evaluated by SI (=CC50/EC50). 
Estimation of CC50 values. Original data contain the sign of
inequality such as ”>”. For the convenience of analysis, these values
were changed into forms suitable for arithmetic calculation. Since
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Figure 1. Structure of 3-styrylchromones. 
“>400” is equal to “from 400 to ∞”, we calculated the harmonic
mean as follows: 1/[average(1/400,1/∞)]=800. Since the CC50
values had a distribution pattern close to a logarithmic normal
distribution, we used the pCC50 (i.e., the −log CC50) for the
comparison of the cytotoxicity between the compounds. The mean
pCC50 values for normal cells and tumor cell lines were defined as
N and T, respectively (16).
Calculation of the representative value for tumor selectivity. Tumor
selectivity is defined by the balance between pCC50 values for
normal (N) and tumor (T) cells. The difference (T−N) was used as
a tumor-selectivity index in the following analyses.
Calculation of chemical descriptors. Each chemical structure was
optimized by the LowModeMD method (17), a suitable search
method for minimum energy conformers of flexible molecules, with
Merck Molecular Force Field (MMFF94x) in Molecular Operating
Environment (MOE) 2013.08 (Chemical Computing Group Inc.,
Quebec, Canada). Each structure was refined with density functional
theory (DFT-B3LYP/6-31G**) by using Spartan10 for Windows
(Wavefunction, Inc., Irvine, CA, USA) (18). The descriptors used
were: R1 OMe (methoxy substitution at the 6-position on the
chromone ring group), R3 OH (4’-hydroxy substitution in the
phenyl group of styryl moiety), vsurf_DD23 (the interaction with
hydrophobic probe assumed surrounding the molecule), G1u (the
first component symmetry directional WHIM index/unweighted
encoding molecular symmetry that extracts the global symmetry
information), G2u (the second component symmetry directional
WHIM index/unweighted encoding molecular symmetry that
extracts the global symmetry information) (19), BCUT_SMR_3
(BCUT descriptor using atomic contribution to molar refractivity),
rgvr (radius of gyration), diameter (largest value in the distance
matrix defined by the elements Dij, where Dij is the length of the
shortest path from atoms i to j). The BCUT descriptors are
calculated from the eigenvalues of a modified adjacency matrix (20).
Statistical treatment. The relation among cytotoxicity, tumor
specificity index, anti-UV activity and chemical descriptors was
investigated using simple regression analyses by JMP Pro version
10.0.2 (SAS Institute Inc., Cary, NC, USA). The significance level
was set at p<0.05.
Results
Cytotoxicity. Among fifteen 3-styrylchromone derivatives,
compound [11] showed the highest cytotoxicity against four
human OSCC cell lines (mean CC50=2.0±1.2 μM) followed
by [4] (6.4±2.4 μM) and [6] (13±6.1 μM) (Table I). Since
these compounds showed much lower cytotoxicity against
three human oral normal cells (mean CC50=138±116,
258±126 and 339±183 μM, respectively), they showed the
highest tumor-selectivity [TS (D/B)=69.0, 40.3 and 26.1,
respectively], comparable with that of doxorubicin (TS=>26)
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Table I. Cytotoxic activity of fifteen 3-styrylchromones. Each value represents the mean of triplicate determinations.
CC50 (μM)
Human oral squamous cell carcinoma cell lines Human normal oral cells
TS
Ca9-22 HSC-2 HSC-3 HSC-4 Mean±S.D. HGF HPLF HPC Mean±SD
3-Styrylchromones (A) (B) (C) (D)/(B) (C)/(A)
1 183 94 200 80 139±61 643 533 475 550±85 4.0 3.5 
2 41 82 41 77 60±22 64 68 156 96±52 1.6 1.6 
3 263 300 278 310 288±21 560 518 715 598±104 2.1 2.1 
4 4.4 4.4 7.7 9.2 6.4±2.4 229 150 396 258±126 40.3 52.0 
5 33 92 36 61 56±27 98 83 171 117±47 2.1 3.0 
6 10 6.8 21 13 13±6.1 544 190 284 339±183 26.1 54.4 
7 43 57 58 38 49±10 140 126 97 121±22 2.5 3.3 
8 13 48 83 204 87±83 554 657 733 648±90 7.4 42.6 
9 23 25 14 28 23±6.0 457 520 600 526±72 22.9 19.9 
10 33 6.3 24 6.3 17±13 154 141 241 179±54 10.5 4.7 
11 2.1 1.0 3.6 1.2 2.0±1.2 67 74 272 138±116 69.0 31.9 
12 25 2.4 32 3.3 16±15 161 187 267 205±55 12.8 6.4 
13 >800 >800 240 >800 >660±280 >800 >800 >800 >800 ><1.2 ><1.0
14 19 11 11 15 14±3.8 19 31 80 43±32 3.1 1.0 
15 33 9.1 22 7.5 18±12 247 222 507 325±158 18.1 7.4 
Positive control
Doxorubicin 0.26 0.12 0.11 0.094 0.15±0.077 0.87 0.87 >10 >3.9±5.3 >26.0 3.3 
5-FU 29 13 16 13 18±7.6 >1000 >1000 >1000 >1000 >55.6 >34.5
HGF, Human gingival fibroblast; HPC, pulp cells; HPLF, periodontal ligament fibroblast; Ca9-22, HSC-2, HSC-3 and HSC-4, oral squamous cell
carcinoma cell lines; TS, tumor selectivity index; CC50, 50% cytotoxic concentration; 5-FU, 5-fluorouracil.
and 5-FU (TS=>55.6) (Table I). When tumor-selectivity was
calculated by different equation using Ca9-22 and HGF cells,
both derived from gingival tissues ([TS(C/A)], these three
compounds again showed very high tumor-selectivity (31.9,
52.0 and 54.4, respectively) (Table I). 
Anti-HIV activity. In contrast to popular anti-HIV agents (dextran
sulfate, curdlan sulfate, azidothymidine, 2’,3’-dideoxycytidine)
(SI=2445-20421), none of 3-styrylchromones 1-15 protected the
cells from the cytopathic effect of HIV infection (SI<1) (Table
II). Based on these data, the following QASR analysis was
focused on the cytotoxicity of 3-styrylchromones. 
Computational analysis. Cytotoxicity of 3-styrylchromones
against tumor cells (defined by T) correlated with descriptors
based on the substituent group. R1 OMe (methoxy substitution
at the 6-position on the chromone ring) (p=0.100) and R3 OH
(4’-hydroxy substitution in the phenyl group of styryl moiety)
(p=0.0182) are crucial for the enhancement of cytotoxicity
against OSCC cell lines (Figure 2).
On the other hand, cytotoxicity of 3-styrylchromones against
normal cells (defined by N) was correlated with vsurf_DD23
(the interaction with hydrophobic probe assumed surrounding
the molecule) (r2=0.413, p=0.0078) and G1u (the first
component symmetry directional WHIM index/unweighted
encoding molecular symmetry that extracts the global
symmetry information) (r2=0.445, p=0.0066) (Figure 3). 
Tumor selectivity of 3-styrylchromones (defined by T-N)
correlated with R3 OH (p=0.0616), vsurf_DD23 (r2=0.280,
p=0.0426) and G2u (the second component symmetry
directional WHIM index/unweighted encoding molecular
symmetry that extracts the global symmetry information)
(r2=0.406, p=0.0106) (Figure 4).
A model for the estimation of T, N and T-N values was
constructed by multiple regression analysis using the
descriptors calculated in this study. T can be estimated by
ANTICANCER RESEARCH 34: 5405-5412 (2014)
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Figure 2. Effects of functional groups on cytotoxicity of 3-styrylchromones against tumor cells (defined as T). The mean (pCC50 i.e., the −log CC50)
values for tumor cell lines were defined as T.
Table II. Anti-HIV activity of 3-styrylchromones and chemotherapeutic
agents. Each value represents the mean of triplicate determinations. 
3-Styrylchromones CC50 (μM) EC50 (μM) SI
1 528.45 >800 <1
2 463.38 >800 <1
3 629.23 >800 <1
4 5.87 >800 <1
5 >800 >800 ><1
6 3.39 >800 <1
7 435.71 >800 <1
8 270.56 >800 <1
9 13.76 >800 <1
10 12.92 >800 <1
11 3.26 >800 <1
12 59.91 >800 <1
13 223.28 >800 <1
14 3.59 >800 <1
15 4.76 >800 <1
Positive controls
Dextran sulfate (μg/ml) 985.6 0.06 17125
Curdlan sulfate (μg/ml) >1000 0.14 >7002
Azidothymidine 222.2 0.011 20421
2',3'-Dideoxycytidine 2511.59 1.03 2445
CC50, 50% Cytotoxic concentration; EC50, 50% effective concentration;
SI: selectivity index (CC50/EC50). 
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Figure 3. Determination coefficient of chemical descriptors and cytotoxicity of 3-styrylchromones against normal cells (defined as N). The mean
(pCC50 i.e., the −log CC50) values for normal cells were defined as N.
Figure 4. Determination coefficient of chemical descriptors and tumor specificity of 3-styrylchromones (defined as T-N). 
Figure 5. Multiple regression models for the estimation of T, N and T-N.
R1 OMe and R3 OH (r2=0.702, Q2=0.532, s=0.409) (left).
N can be estimated by BCUT_SMR_3, rgyr (radius of
gyration) and vsurf_DD23 (R2=0.834, Q2=0.695, s=0.194)
(left). T-N can be estimated by diameter (largest value in
the distance matrix defined by the elements Dij),
vsurf_DD23 and R3 OH (R2=0.764, Q2=0.570, s=0.308)
(right) (Figure 5).
Discussion
The present study demonstrated for the first time that fifteen
3-styrylchromones showed moderate-to-potent tumor-
specificity and no detectable anti-HIV activity (Table I).
Three compounds [4, 6, 11] showed the highest tumor-
selectivity, comparable to doxorubicin and 5-FU (Table I).
The lack of anti-HIV activity is not in agreement with a
previous study where 4H-chromen-4-one and 2H-chromene
derivatives inhibited the replication of picornavirus in vitro
(9). The discrepancy between our and their results may be
due to the fact that they did not produce the
chemotherapeutic index (safety margin).
The present study is the first report of QSAR analysis of
3-styrylchromones. We used the following soft Spartan (34
quantum chemistry-related descriptors), MOE (330 quantum
chemistry, structure and physical chemistry-related
descriptors), dragon (114 three-dimensional molecular shape-
related descriptors) and 9 descriptors (that relate the location
of substituent groups and types). The valuables used are T,
N and T-N. Descriptors that showed significant difference or
significant trends (p≤0.1) were R1 OMe (methoxy
substitution at the 6-position on the chromone ring), R3 OH
(4’-hydroxy substitution in the phenyl group of styryl
moiety), vsurf_DD23, G1u and G2u.
Van der Waals interaction through the methoxy
substitution at the 6-position and the hydrogen bonding
through the 4’-hydroxy substitution may be important for the
interaction with key proteins engaged in the cytotoxicity
against OSCC cells (Figure 2). Hydrophobic interaction and
molecular shape may be important for the cytotoxicity
against normal cells (Figure 3). Molecular shape and 4’-
hydroxy substitution in the phenyl group of styryl moiety
affected the tumor-selectivity (Figure 4).
For the multiple regression analysis model, the following
descriptors were used: BCUT_SMR_3 (that relates to the
topological shape of molecule and the interaction between
the low molecular weight molecule and protein interaction),
rgvr (that relates to the molecular size and shape) and
diameter (that reflects the topological size of molecule).
Leave-one-out cross verification method confirmed that
cytotoxicity against OSCC cells (T), oral normal cells (N)
and tumor-specificity (T-N) can be estimated by the
combination of descriptors for substituent groups, molecular
shape and hydrophobic interaction (Figure 5).
We have previously reported that 2-styrylchromone
derivatives having methoxy group in the phenyl group of
styryl moiety showed relatively higher tumor-selectivity and
induced apoptosis in the human promyelocytic leukemia HL-
60 cell line and non-apoptosis in the human oral squamous
cell carcinoma HSC-2 cell line (4). In contrast, tumor-
selectivity of 3-styrylchromones was significantly enhanced
by the introduction of methoxy group on the chromone ring
and hyxroxyl group in the phenyl group of styryl moiety. It
remains to be investigated which type of cell death is
induced by 3-styrylchromones in OSCC cell lines. 
In conclusion, the present study demonstrated that 3-
styrylchromones substituted with methoxy group on the
chromone ring and hydroxy group in the phenyl group of
styryl moiety are promising for the exploration of new anti-
tumor agents. Multivariate statistics with chemical descriptors
for the location of substituted group, molecular shape and
electrostatic interaction may be useful for designing the most
favorable compound with higher tumor selectivity.
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